Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 447

1.

[Expression and Clinical Significance of C/EBPα Gene in Elderly Multiple Myeloma].

Zang YZ, Chen XL, Bai YL, Zhang WH, Yu RH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Feb;27(1):123-128. doi: 10.7534/j.issn.1009-2137.2019.01.020. Chinese.

PMID:
30738458
2.

Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia.

Akin DF, Oner DA, Kurekci E, Akar N.

Bratisl Lek Listy. 2018;119(6):366-372. doi: 10.4149/BLL_2018_068.

PMID:
29947237
3.

C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia.

Loke J, Chin PS, Keane P, Pickin A, Assi SA, Ptasinska A, Imperato MR, Cockerill PN, Bonifer C.

Blood Adv. 2018 Feb 13;2(3):271-284. doi: 10.1182/bloodadvances.2017012781.

4.

CEBPA mutational analysis in acute myeloid leukaemia by a laboratory-developed next-generation sequencing assay.

Ng CWS, Kosmo B, Lee PL, Lee CK, Guo J, Chen Z, Chiu L, Lee HK, Ho S, Zhou J, Lin M, Tan KML, Ban KHK, Tan TW, Chng WJ, Yan B.

J Clin Pathol. 2018 Jun;71(6):522-531. doi: 10.1136/jclinpath-2017-204825. Epub 2017 Nov 27.

PMID:
29180507
5.

C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting β-Catenin.

Lu J, Du C, Yao J, Wu B, Duan Y, Zhou L, Xu D, Zhou F, Gu L, Zhou H, Sun Y.

Cell Physiol Biochem. 2017;42(5):1779-1788. doi: 10.1159/000479457. Epub 2017 Jul 26.

6.

C/EBPα deregulation as a paradigm for leukemogenesis.

Pulikkan JA, Tenen DG, Behre G.

Leukemia. 2017 Nov;31(11):2279-2285. doi: 10.1038/leu.2017.229. Epub 2017 Jul 19. Review.

PMID:
28720765
7.

Comprehensive Myocardial Proteogenomics Profiling Reveals C/EBPα as the Key Factor in the Lipid Storage of ARVC.

Chen L, Yang F, Chen X, Rao M, Zhang NN, Chen K, Deng H, Song JP, Hu SS.

J Proteome Res. 2017 Aug 4;16(8):2863-2876. doi: 10.1021/acs.jproteome.7b00165. Epub 2017 Jul 13.

PMID:
28665611
8.

CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features.

Mannelli F, Ponziani V, Bencini S, Bonetti MI, Benelli M, Cutini I, Gianfaldoni G, Scappini B, Pancani F, Piccini M, Rondelli T, Caporale R, Gelli AM, Peruzzi B, Chiarini M, Borlenghi E, Spinelli O, Giupponi D, Zanghì P, Bassan R, Rambaldi A, Rossi G, Bosi A.

Haematologica. 2017 Mar;102(3):529-540. doi: 10.3324/haematol.2016.151910. Epub 2016 Nov 10.

9.

Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.

Avellino R, Delwel R.

Blood. 2017 Apr 13;129(15):2083-2091. doi: 10.1182/blood-2016-09-687822. Epub 2017 Feb 8. Review.

10.

Comprehensive population-based genome sequencing provides insight into hematopoietic regulatory mechanisms.

Guo MH, Nandakumar SK, Ulirsch JC, Zekavat SM, Buenrostro JD, Natarajan P, Salem RM, Chiarle R, Mitt M, Kals M, Pärn K, Fischer K, Milani L, Mägi R, Palta P, Gabriel SB, Metspalu A, Lander ES, Kathiresan S, Hirschhorn JN, Esko T, Sankaran VG.

Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E327-E336. doi: 10.1073/pnas.1619052114. Epub 2016 Dec 28.

11.

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.

Konopka B, Szafron LM, Kwiatkowska E, Podgorska A, Zolocinska A, Pienkowska-Grela B, Dansonka-Mieszkowska A, Balcerak A, Lukasik M, Stachurska A, Timorek A, Spiewankiewicz B, El-Bahrawy M, Kupryjanczyk J.

Oncotarget. 2016 Oct 11;7(41):67412-67424. doi: 10.18632/oncotarget.11822.

12.

The role of C/EBP-α expression in human liver and liver fibrosis and its relationship with autophagy.

Tao LL, Zhai YZ, Ding D, Yin WH, Liu XP, Yu GY.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13102-7. eCollection 2015.

13.

Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family.

Pathak A, Seipel K, Pemov A, Dewan R, Brown C, Ravichandran S, Luke BT, Malasky M, Suman S, Yeager M; NCI DCEG Cancer Genomics Research Laboratory; NCI DCEG Cancer Sequencing Working Group, Gatti RA, Caporaso NE, Mulvihill JJ, Goldin LR, Pabst T, McMaster ML, Stewart DR.

Haematologica. 2016 Jul;101(7):846-52. doi: 10.3324/haematol.2015.130799. Epub 2015 Dec 31.

14.

Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.

Ahn JS, Kim JY, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Minden MD, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD.

Ann Hematol. 2016 Jan;95(2):301-10. doi: 10.1007/s00277-015-2540-7. Epub 2015 Nov 4. Erratum in: Ann Hematol. 2016 Jan;95(2):363.

PMID:
26537612
15.

Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.

Bueno C, Sardina JL, Di Stefano B, Romero-Moya D, Muñoz-López A, Ariza L, Chillón MC, Balanzategui A, Castaño J, Herreros A, Fraga MF, Fernández A, Granada I, Quintana-Bustamante O, Segovia JC, Nishimura K, Ohtaka M, Nakanishi M, Graf T, Menendez P.

Leukemia. 2016 Mar;30(3):674-82. doi: 10.1038/leu.2015.294. Epub 2015 Oct 26.

PMID:
26500142
16.

CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis.

Libura M, Pawełczyk M, Florek I, Matiakowska K, Jaźwiec B, Borg K, Solarska I, Zawada M, Czekalska S, Libura J, Salamanczuk Z, Jakóbczyk M, Mucha B, Duszeńko E, Soszyńska K, Karabin K, Piątkowska-Jakubas B, Całbecka M, Gajkowska-Kulig J, Gadomska G, Kiełbiński M, Ejduk A, Kata D, Grosicki S, Kyrcz-Krzemień S, Warzocha K, Kuliczkowski K, Skotnicki A, Jęrzejczak WW, Haus O.

Blood Cells Mol Dis. 2015 Dec;55(4):284-92. doi: 10.1016/j.bcmd.2015.07.002. Epub 2015 Jul 7.

PMID:
26460249
17.

Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.

Wang L, Xiao H, Zhang X, Liao W, Fu S, Huang H.

Int J Oncol. 2015 Nov;47(5):1685-95. doi: 10.3892/ijo.2015.3163. Epub 2015 Sep 14.

18.

Disease evolution and outcomes in familial AML with germline CEBPA mutations.

Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C, Savic A, Van Delft FW, Treleaven J, Georgiades P, Uglow E, Asou N, Uike N, Debeljak M, Jazbec J, Ancliff P, Gale R, Thomas X, Mialou V, Döhner K, Bullinger L, Mueller B, Pabst T, Stelljes M, Schlegelberger B, Wozniak E, Iqbal S, Okosun J, Araf S, Frank AK, Lauridsen FB, Porse B, Nerlov C, Owen C, Dokal I, Gribben J, Smith M, Preudhomme C, Chelala C, Cavenagh J, Fitzgibbon J.

Blood. 2015 Sep 3;126(10):1214-23. doi: 10.1182/blood-2015-05-647172. Epub 2015 Jul 10.

19.

CEBPA methylation and mutation in myelodysplastic syndrome.

Wen XM, Hu JB, Yang J, Qian W, Yao DM, Deng ZQ, Zhang YY, Zhu XW, Guo H, Lin J, Qian J.

Med Oncol. 2015 Jul;32(7):192. doi: 10.1007/s12032-015-0605-z. Epub 2015 May 30.

PMID:
26025484
20.

Characterization of CEBPA Mutations and Polymorphisms and their Prognostic Relevance in De Novo Acute Myeloid Leukemia Patients.

Sarojam S, Raveendran S, Vijay S, Sreedharan J, Narayanan G, Sreedharan H.

Asian Pac J Cancer Prev. 2015;16(9):3785-92.

Supplemental Content

Support Center